Verrica Pharmaceuticals I... (VRCA)
NASDAQ: VRCA
· Real-Time Price · USD
0.61
-0.01 (-1.61%)
At close: May 23, 2025, 3:59 PM
0.61
0.39%
After-hours: May 23, 2025, 04:02 PM EDT
Verrica Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Collaboration Revenue | 992K | 466K |
| Collaboration Revenue Growth | +112.88% | n/a |
| Product Revenue | 6.57M | 4.66M |
| Product Revenue Growth | +41.13% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.85M | 9.88M | 16.08M | 16.52M | 16.34M | 16.89M | 20.05M | 5.94M | 4.32M | 3.19M | 3.92M | 5.17M | 5.12M | 5.11M | 8.01M | 7.28M | 6.58M | 9.76M | 4.65M | 5.11M | 4.99M | 4.02M | 3.49M | 3.59M | 3.54M | 3.27M | 3.68M | 2.5M | 986K | 316K | 238K | 118K | 55K |
| Selling, General, and Administrative Revenue Growth | -10.43% | -38.58% | -2.66% | +1.12% | -3.24% | -15.79% | +237.78% | +37.46% | +35.43% | -18.75% | -24.13% | +1.07% | +0.10% | -36.13% | +9.90% | +10.73% | -32.61% | +109.96% | -9.02% | +2.45% | +24.14% | +15.00% | -2.76% | +1.53% | +8.19% | -11.14% | +47.06% | +153.85% | +212.03% | +32.77% | +101.69% | +114.55% | n/a |
| Research and Development Revenue | 2.28M | 1.17M | 2.4M | 3.32M | 4.95M | 5.32M | 6.51M | 5.72M | 2.74M | 3.03M | 2.95M | 4.16M | 2.72M | 3.36M | 3.76M | 3.45M | 5.36M | 2.27M | 4.99M | 3.52M | 4.89M | 3.97M | 3.05M | 3.93M | 4.49M | 4.92M | 3.48M | 3.61M | 929K | 1.12M | 1.12M | 977K | 515K |
| Research and Development Revenue Growth | +95.72% | -51.48% | -27.54% | -32.92% | -6.99% | -18.28% | +13.71% | +109.02% | -9.60% | +2.85% | -29.22% | +52.85% | -18.89% | -10.79% | +9.17% | -35.71% | +136.00% | -54.45% | +41.66% | -28.03% | +23.16% | +30.27% | -22.38% | -12.46% | -8.75% | +41.13% | -3.46% | +288.48% | -16.91% | -0.18% | +14.64% | +89.71% | n/a |